Similarly, RP11-296E3.2 plays a crucial role in the oncogenic YBX1/STAT3 axis that drives CRC metastasis, suggesting that it could be used as a prognostic marker and a therapeutic target in mCRC. Here, YBX1 is linked to colorectal carcinoma.